Results of the phase 1b study of ABBV-399 (telisotuzumab vedotin; teliso-v) in combination with erlotinib in patients with c-Met+ non-small cell lung cancer by EGFR mutation status. This is an ASCO ...
A pilot study of the safety, efficacy, and effects on functional imaging of the combination of cG250 and sunitinib in patients (pts) with advanced renal cell carcinoma (RCC). A multicenter, randomized ...
The results of the first 'Phase 0' clinical trial in oncology of a therapeutic agent under the Exploratory Investigational New Drug Guidance of the US FDA have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results